Automera
@automeratx.com
Automera is an early-stage company focused on the development of a novel therapeutic approach via autophagy-based targeted protein degradation. Automera aims to leverage its unique understanding of autophagy, drug development capabilities, and access to quantum chemistry and generative AI-enabled insights to enhance its drug development programs. Automera’s AUTAC platform has broad potential across cancer and other disease areas, with oncology being the initial lead program. The company was founded by co-founders Associate Professor Michael Lazarou, Loong Wang, and Taiyang Zhang at Talo Labs Pte Ltd.
Automera's Company Logos
Automera's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#1B5ACA
Denim
27, 90, 202
218, 76, 45
87, 55, 0, 21
#89B7E9
Cornflower
137, 183, 233
211, 69, 73
41, 21, 0, 9
#020381
Navy Blue
2, 3, 129
240, 97, 26
98, 98, 0, 49
About Automera
Automera is a brand dedicated to developing cutting-edge technology that simplifies and accelerates the process of creating superior drugs. Their expertise lies in harnessing the power of autophagy, a mechanism of cellular degradation, which offers a wide range of applications and opportunities in the field of medicine. The team at Automera consists of highly accomplished professionals who bring extensive experience and knowledge to their work.
Dr. Mahmood Ahmed, the Chief Scientific Officer, has over 20 years of experience in medicinal chemistry and drug discovery. Dr.
Shawn Hoon, the Chief Innovation Officer, is a renowned researcher in chemogenomics, protein engineering, and synthetic biology. And Dr. Michael Lazarou, a Co-Founder, is a respected authority in the study of autophagy and selective autophagy research.
Automera is supported by a distinguished panel of scientific advisors, including Dr. Gene Yeo, a Professor of Cellular and Molecular Medicine, and Dr. Nicholas Ktistakis, an expert in lipid signaling and autophagy initiation.
With their commitment to innovation and collaboration, Automera is poised to revolutionize the drug development process and make significant contributions to the field of medicine. Connect with them on LinkedIn and Twitter to stay updated on their groundbreaking work
Company type
Privately Held
Year founded
2022
Company size
2-10 employees
